DOCSLIB.ORG

Supplemental Data

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplemental Data Supplemental Table 1. ICD9 codes Disease ICD9 codes Cataract 366 Muscular dystrophies and other 359 myopathies Inflammation of uvea 360, 363, 364 Intraocular cancer 190 Ocular trauma 871, 921 Diabetes 249, 250 Hypertension 401 Hyperlipidemia 272 Chronic kidney disease 585, 586, 5880, 5888, 5889 Chronic obstructive pulmonary 491, 492, 496 diseases 291, 303, 3050, 3575, 4255, 5353, 5710, 5711, Alcoholic related diseases 5712, 5713 THE JOURNAL OF NUCLEAR MEDICINE • Vol. 57 • No. 6 • June 2016 Lin et al. Supplemental Table 2. ATC codes of drugs Drug ATC codes Aspirin B01AC06, N02BA01 Statin C10AA, C10B Metformin A10BA02 Angiotensin converting enzyme C09A, C09B inhibitor Angiotensin receptor blocker C09C, C09D Estrogen G03C, G03F Progesterone G03D, G03F Steroid, oral H02AB, H02B, M01MA Steroid, inhaled R03BA Steroid, nasal R01AD Steroid, eyedrops S01BA, S01BB, S01CA, S01CB THE JOURNAL OF NUCLEAR MEDICINE • Vol. 57 • No. 6 • June 2016 Lin et al. Supplemental Table 3. Drug codes or order codes used in Taiwan NHI dataset Drug or order Codes in Taiwan NHI dataset Cataract surgery 86007C, 86008C Capsulectomy 86006C Intraocular surgery 85213B, 85805C, 85806C, 85816B, 85823B, 86206B, 86207B, 86213B, 86214C, 86401B, 86407B, 86408B Slitlamp examination 23401C Pirenoxine A021747435, B021053435, B021309435, B021628421 Azapentacene B022417421, B022417435, B023688421, B023688435 Chemotherapy 37005B, 37025B, 37031B, 37032B, 37033B, 37034B, 37035B, 37036B, 37037B, 37038B, 37039B, 37040B, 37041B, Radiotherapy 36001B, 36002B, 36004B, 36005B, 36006B, 36009B, 36010B, 36011B, 36012B, 36013B, 36014B, 36015B, 36016B, 36017B, 36018B, 36019B, 36020B, 36021C, 37028B, 37029B, Computerized tomography 33067B, 33068B, 33069B, 33070B, 33070BA, 33071B, 33072B Head X-ray 32009C, 32010C, 34001C, 34002C, 34003C, 34004C, 34005B, 34006B Esophagography 33004B Upper gastrointestinal series 33006B Small bowel series 33008B Upper gastrointestinal and small bowel 33009B series Lower gastrointestinal series 33010B Double-contrast study of lower 33011B gastrointestinal series Double contrast small bowel series. 33082A, 33082B Coronary angiography 33076A, 33076B, 33077A, 33077B, 33078A, 33078B, 18020A, 18020B, 18021A, 18021B, 97501K, 97502A, 97503B, 97506K, 97507A, 97508B, 97511K, 97512A, 97513B, 97516K, 97517A, 97518B, 97521K, 97522A, 97523B Aortography/noncardiac angiography 33041B, 33042B, 33043B, 33044B, 33045B, 33046B, 33047B, 33048B, 33061B, 33062B, 33073A, 33073B, 33086B, 33087B, 33088B, 33089B t-tube cholecystography 33022B Operative cholangiography 33023B Endoscopic retrograde 33024B cholangiopancreatography THE JOURNAL OF NUCLEAR MEDICINE • Vol. 57 • No. 6 • June 2016 Lin et al. Endoscopic retrograde pancreas drainage 33033B, 33033BA, 33033BB Percutaneous transhepatic cholangiography 33025B Percutaneous transhepatic cholangiography- 33026B, 33027B, 33080B, 33083B drainage Percutaneous gall bladder drainage 33079A1, 33106B Percutaneous transluminal angioplasty 33074A, 33074B, 33115B Transarterial embolization 33075A, 33075B Percutaneous nephrostomy 33027BA, 33032B, 33095B Hysterosalpingography 33029B Myelography 33054B, 33055B, 33056B, 33057B, 33058B Percutaneous vertebroplasty and venography 33126B, 33127B 99mTc- methyldiphosphonate bone scan 26029A, 26029B, 26057A, 26057B, 26058A, 26058B, 26076B 201Tl whole body scan 26013A, 26013B 67Ga scan 26030A, 26030B, 26031A, 26031B 99mTc labelled red blood cell scan 26027A, 26027B, 26044A, 26044B, 26045A, 26045B, 26047A, 26047B, 26048A, 26048B, 26060A, 26060B 18F- fluorodeoxyglucose positron emission 26072C, 26072B, 26073C, 26073B tomography scan Parathyroid scan 26055A, 26055B Sialoscintigraphy 26051A, 26051B 131I thyroid scan 26005A, 26005B 99mTc thyroid scan 26004A, 26004B THE JOURNAL OF NUCLEAR MEDICINE • Vol. 57 • No. 6 • June 2016 Lin et al. THE JOURNAL OF NUCLEAR MEDICINE • Vol. 57 • No. 6 • June 2016 Lin et al. .
Load more

Recommended publications
  • Focal Spot, Spring 2006
    Washington University School of Medicine Digital Commons@Becker Focal Spot Archives Focal Spot Spring 2006 Focal Spot, Spring 2006 Follow this and additional works at: http://digitalcommons.wustl.edu/focal_spot_archives Recommended Citation Focal Spot, Spring 2006, April 2006. Bernard Becker Medical Library Archives. Washington University School of Medicine. This Book is brought to you for free and open access by the Focal Spot at Digital Commons@Becker. It has been accepted for inclusion in Focal Spot Archives by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. SPRING 2006 VOLUME 37, NUMBER 1 *eiN* i*^ MALLINCKRC RADIOLO AJIVERSITY *\ irtual Colonoscopy: a Lifesaving Technology ^.IIMi.|j|IUII'jd-H..l.i.|i|.llJ.lii|.|.M.; 3 2201 20C n « ■ m "■ ■ r. -1 -1 NTENTS FOCAL SPOT SPRING 2006 VOLUME 37, NUMBER 1 MIR: 75 YEARS OF RADIOLOGY EXPERIENCE In the early 1900s, radiology was considered by most medical practitioners as nothing more than photography. In this 75th year of Mallinckrodt Institute's existence, the first of a three-part series of articles will chronicle the rapid advancement of radiol- ogy at Washington University and the emergence of MIR as a world leader in the field of radiology. THE METABOLISM OF THE DIABETIC HEART More diabetic patients die from cardiovascular disease than from any other cause. Researchers in the Institute's Cardiovascular Imaging Laboratory are finding that the heart's metabolism may be one of the primary mechanisms by which diseases such as diabetes have a detrimental effect on heart function. VIRTUAL C0L0N0SC0PY: A LIFESAVING TECHNOLOGY More than 55,000 Americans die each year from cancers of the colon and rectum.
    [Show full text]
  • SAGES Clinical Spotlight Review: Intraoperative Cholangiography
    SAGES Clinical Spotlight Review: Intraoperative cholangiography William W. Hope, MD, Robert Fanelli MD, Danielle S. Walsh MD, Ray Price MD, Dimitrios Stefanidis MD, William S. Richardson MD, and the SAGES Guidelines Committee Preamble The following clinical spotlight review regarding the intraoperative cholangiogram is intended for physicians who manage and treat gallbladder/biliary pathology and perform laparoscopic cholecystectomy. It is meant to critically review the technique of intraoperative cholangiography, alternatives for intraoperative biliary imaging, and the available evidence supporting their safety and efficacy. Based on the level of evidence, recommendations may or may not be given for their use in clinical practice. Disclaimer Guidelines for clinical practice and spotlight reviews are intended to indicate preferable approaches to medical problems as established by experts in the field. These recommendations will be based on existing data or a consensus of expert opinion when little or no data are available. Spotlight reviews are applicable to all physicians who address the clinical problem(s) without regard to specialty training or interests, and are intended to convey recommendations based on a focused topic; within the defined scope of review, they indicate the preferable, but not necessarily the only acceptable approaches due to the complexity of the healthcare environment. Guidelines and recommendations are intended to be flexible. Given the wide range of specifics in any health care problem, the surgeon must always choose the course best suited to the individual patient and the variables in existence at the moment of decision. Guidelines, spotlight reviews, and recommendations are developed under the auspices of the Society of American Gastrointestinal Endoscopic Surgeons and its various committees, and approved by the Board of Governors.
    [Show full text]
  • Imaging in Double Gall Bladder with Acute Cholecystitis—A Rare Entity
    Surgical Science, 2014, 5, 273-279 Published Online July 2014 in SciRes. http://www.scirp.org/journal/ss http://dx.doi.org/10.4236/ss.2014.57047 Imaging in Double Gall Bladder with Acute Cholecystitis—A Rare Entity Praveen Kumar Vasanthraj, Rajoo Ramachandran, Kumaresh Athiyappan, Anupama Chandrasekharan, Cunnigaiper Dhanasekaran Narayanan Department of Radiology, Sri Ramachandra University, Chennai, India Email: [email protected] Received 28 April 2014; revised 26 May 2014; accepted 22 June 2014 Copyright © 2014 by authors and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/ Abstract Duplication of gall bladder is a rare congenital anomaly of the hepatobiliary system. It is a very important entity in clinical practice as preoperative diagnosis plays a significant role in the man- agement and to avoid unnecessary bile duct injury during surgery. We report a case of duplicated gall bladder presenting as acute cholecystitis. Keywords Gall Bladder, Duplication, Cholecystitis 1. Introduction Gall bladder (GB) duplication is a rare congenital anomaly of hepatobiliary system with a reported incidence of about 1 per 4000 autopsies [1]. Duplication of gall bladder and their varying anatomical positions are associated with an increased risk of complications including biliary leak after laparoscopic or open cholecystectomy [2]-[5]. 2. Case Presentation A 45 years old lady presented with complaints of abdomen pain for the past two days. It was colicky type pain, intermittent in nature and localized to the right hypochondrium. She also gave history of three episodes of vo- miting which was non bilious, non blood stained and non foul smelling.
    [Show full text]
  • Impact of Preoperative Endoscopic Ultrasound in Surgical Oncology
    REVIEW Impact of preoperative endoscopic ultrasound in surgical oncology Endoscopic ultrasound (EUS) has a strong impact on the imaging and staging of solid tumors within or in close proximity of the upper GI tract. Technological developments during the last two decades have increased the image quality and allowed very detailed visualization of local tumor spread and lymph node affection. Current indications for EUS of the upper GI tract encompass the differentiation between benign and malignant lesions, the staging of esophageal, gastric and pancreatic cancer, and the procurement of a biopsy specimen through fine-needle aspiration. Various technical innovations during the past two decades have increased the diagnostic quality and have simultaneously strengthened the role of EUS in the clinical setting. This article will give a compressed summary on the current state of EUS and possible further technical developments. 1 KEYWORDS: 3D imaging elastosonography endoscopic ultrasound miniprobes Sascha S Chopra & oncologic surgery Michael Hünerbein† 1Department of General & Transplantation Surgery, Charité Campus Virchow-Clinic, Berlin, Conventional endoscopic ultrasound the so-called ‘miniprobes’ into the biliary system Germany Linear versus radial systems or the pancreatic duct in order to obtain high-res- †Author for correspondence: Department of Surgery & Surgical Endoscopic ultrasound (EUS) with flex- olution radial ultrasound images locally. Present Oncology, Helios Hospital Berlin, ible endoscopes is an important diagnostic and mini probes show a diameter of 2–3 mm and oper- 13122 Berlin, Germany Tel.: +49 309 417 1480 therapeutic tool, especially for the local staging ate with frequencies between 12 and 30 MHz. Fax: +49 309 417 1404 of gastrointestinal (GI) cancers, the differen- The main drawbacks of these devices are the lim- michael.huenerbein@ tiation between benign and malignant tumors, ited durability and the decreased depth of penetra- helios-kliniken.de and interventional procedures, such as biopsies tion (~2 cm).
    [Show full text]
  • F • High Accuracy Sonographic Recognition of Gallstones
    517 - • High Accuracy Sonographic f Recognition of Gallstones Paul C. Messier1 Recent advances in the imaging capabilities of gray scale sonography have increased Donald S. Hill1 the accuracy with which gallstones may be diagnosed. Since the sonographic diagnosis Frank M. Detorie2 of gallstones is often followed by surgery without further confirmatory studies, the Albert F. Rocco1 avoidance of false-positive diagnoses assumes major importance. In an attempt to improve diagnostic accuracy, 420 gallbladder sonograms were evaluated for gall- stones. Positive diagnoses were limited to cases in which the gallbladder was well visualized and contained densities that produced acoustic shadowing or moved rapidly with changes in position. Gallstones were diagnosed in 123 cases and surgery or autopsy in 70 of these patients confirmed stones in 69. There was one false-positive, an accuracy rate for positive diagnosis of 98.6%. Five cases were called indeterminate for stones; one of these had tiny 1 mm stones at surgery. The other four cases had no surgery. Of 276 cases called negative for stones, two were operated. One contained tiny 1 mm stones; the other had no stones. None of the 146 cases with negative sonograms and oral cholecystography or intravenous cholangiography had stones diagnosed by these methods. Because of its ease and simplicity, sonography is attractive as the initial study in patients suspected of having gallstones. With the criteria used here, a diagnosis of gallstones in the gallbladder can be offered with great confidence. Since 1974, the imaging capabilities of gray scale sonography have improved steadily, with corresponding increases in its accuracy in gallstone recognition.
    [Show full text]
  • ACR Manual on Contrast Media
    ACR Manual On Contrast Media 2021 ACR Committee on Drugs and Contrast Media Preface 2 ACR Manual on Contrast Media 2021 ACR Committee on Drugs and Contrast Media © Copyright 2021 American College of Radiology ISBN: 978-1-55903-012-0 TABLE OF CONTENTS Topic Page 1. Preface 1 2. Version History 2 3. Introduction 4 4. Patient Selection and Preparation Strategies Before Contrast 5 Medium Administration 5. Fasting Prior to Intravascular Contrast Media Administration 14 6. Safe Injection of Contrast Media 15 7. Extravasation of Contrast Media 18 8. Allergic-Like And Physiologic Reactions to Intravascular 22 Iodinated Contrast Media 9. Contrast Media Warming 29 10. Contrast-Associated Acute Kidney Injury and Contrast 33 Induced Acute Kidney Injury in Adults 11. Metformin 45 12. Contrast Media in Children 48 13. Gastrointestinal (GI) Contrast Media in Adults: Indications and 57 Guidelines 14. ACR–ASNR Position Statement On the Use of Gadolinium 78 Contrast Agents 15. Adverse Reactions To Gadolinium-Based Contrast Media 79 16. Nephrogenic Systemic Fibrosis (NSF) 83 17. Ultrasound Contrast Media 92 18. Treatment of Contrast Reactions 95 19. Administration of Contrast Media to Pregnant or Potentially 97 Pregnant Patients 20. Administration of Contrast Media to Women Who are Breast- 101 Feeding Table 1 – Categories Of Acute Reactions 103 Table 2 – Treatment Of Acute Reactions To Contrast Media In 105 Children Table 3 – Management Of Acute Reactions To Contrast Media In 114 Adults Table 4 – Equipment For Contrast Reaction Kits In Radiology 122 Appendix A – Contrast Media Specifications 124 PREFACE This edition of the ACR Manual on Contrast Media replaces all earlier editions.
    [Show full text]
  • Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement
    Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement Harvey A. Ziessman, MD; Douglas A. Jones, MD; Larry R. Muenz, PhD; and Anup K. Agarval, MS Department of Radiology, Georgetown University Hospital, Washington, DC Fatty meals have been used by investigators and clini- The purpose of this investigation was to evaluate the use of a cians over the years to evaluate gallbladder contraction in commercially available lactose-free fatty-meal food supple- conjunction with oral cholecystography, ultrasonography, ment, as an alternative to sincalide cholescintigraphy, to de- and cholescintigraphy. Proponents assert that fatty meals velop a standard methodology, and to determine normal gall- are physiologic and low in cost. Numerous different fatty bladder ejection fractions (GBEFs) for this supplement. meals have been used. Many are institution specific. Meth- Methods: Twenty healthy volunteers all had negative medical histories for hepatobiliary and gallbladder disease, had no per- odologies have differed, and few investigations have stud- sonal or family history of hepatobiliary disease, and were not ied a sufficient number of subjects to establish valid normal taking any medication known to affect gallbladder emptying. All GBEFs for the specific meal. Whole milk and half-and-half were prescreened with a complete blood cell count, compre- have the advantage of being simple to prepare and admin- hensive metabolic profile, gallbladder and liver ultrasonography, ister (4–7). Milk has been particularly well investigated. and conventional cholescintigraphy. Three of the 20 subjects Large numbers of healthy subjects have been studied, a were eliminated from the final analysis because of an abnormal- clear methodology described, and normal values determined ity in one of the above studies.
    [Show full text]
  • Answer Key Chapter 1
    Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 1 of 101 Answer Key Chapter 1 Introduction to Clinical Coding 1.1: Self-Assessment Exercise 1. The patient is seen as an outpatient for a bilateral mammogram. CPT Code: 77055-50 Note that the description for code 77055 is for a unilateral (one side) mammogram. 77056 is the correct code for a bilateral mammogram. Use of modifier -50 for bilateral is not appropriate when CPT code descriptions differentiate between unilateral and bilateral. 2. Physician performs a closed manipulation of a medial malleolus fracture—left ankle. CPT Code: 27766-LT The code represents an open treatment of the fracture, but the physician performed a closed manipulation. Correct code: 27762-LT 3. Surgeon performs a cystourethroscopy with dilation of a urethral stricture. CPT Code: 52341 The documentation states that it was a urethral stricture, but the CPT code identifies treatment of ureteral stricture. Correct code: 52281 4. The operative report states that the physician performed Strabismus surgery, requiring resection of the medial rectus muscle. CPT Code: 67314 The CPT code selection is for resection of one vertical muscle, but the medial rectus muscle is horizontal. Correct code: 67311 5. The chiropractor documents that he performed osteopathic manipulation on the neck and back (lumbar/thoracic). CPT Code: 98925 Note in the paragraph before code 98925, the body regions are identified. The neck would be the cervical region; the thoracic and lumbar regions are identified separately. Therefore, three body regions are identified. Correct code: 98926 Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 2 of 101 6.
    [Show full text]
  • MRCP Vs. ERCP
    MRCPMRCP vs.vs. ERCPERCP SteveSteve Harrell,Harrell, MD,MD, MSPHMSPH AdvancedAdvanced TherapeuticTherapeutic EndoscopyEndoscopy DecemberDecember 6,6, 20072007 University of Louisville InitialInitial ThoughtsThoughts ““So,So, itit isis mymy predictionprediction thatthat MRCPMRCP willwill havehave aa hugehuge effecteffect onon ERCPERCP practicepractice inin thethe UnitedUnited States.States.”” ““IfIf II hadhad aa pancreaticpancreatic oror biliarybiliary problemproblem II wouldwould searchsearch outout …… aa centercenter withwith thethe mostmost sophisticatedsophisticated noninvasivenoninvasive techniquestechniques…… veryvery quickly.quickly.”” ““WeWe allall wantwant thethe bestbest forfor ourour patients;patients; shouldshould wewe treattreat themthem differentlydifferently thanthan wewe wouldwould ourselves?ourselves?”” 5/15/985/15/98 Peter B. Cotton, MD, FRCP Medical University of South Carolina Charleston, South Carolina Universityhttp://www.ddc.musc.edu/ddc_pro/pro_development of Louisville /hot_topics/impact_MRCP-cotton.htm LearningLearning GoalsGoals KnowKnow whatwhat ERCPERCP andand MRCPMRCP standstand forfor AdvantagesAdvantages andand disadvantagesdisadvantages ofof MRCPMRCP IndicationsIndications forfor ERCPERCP PoorPoor IndicationsIndications forfor ERCPERCP ClinicalClinical UseUse inin commoncommon disordersdisorders forfor MRCPMRCP EffectsEffects ofof MRCPMRCP onon ERCPERCP inin trainingtraining CasesCases University of Louisville ERCPERCP EndoscopicEndoscopic retrograderetrograde cholangiopancreatographycholangiopancreatography
    [Show full text]
  • Chapter One General Introduction
    Chapter One General Introduction 1.1Introduction: Magnetic resonance cholangiopancreatography (MRCP) is an abdominal magnetic resonance imaging method that allows non-invasive visualization of the pancreatobiliary tree and requires no administration of contrast agent. (Adamek HE et al, 1998). MRCP is increasingly being used as a non-invasive alternative to ERCP and a high percentage of the diagnostic results of MRCP are comparable with those from ERCP for various hepatobiliary pathologies. (Vogl TJ et al.2006). It has been exactly two decades since magnetic resonancecholangiopancreatography (MRCP) was first described. Over this time, the technique has evolved considerably, aided by improvements in spatial resolution and speed of acquisition. It has now an established role in the investigation of many biliary disorders, serving as a non-invasive alternative to endoscopic retrograde cholangiopancreatography (ERCP).It makes use of heavily T2-weighted pulse sequences, thus exploiting the inherent differences in the T2-weighted contrast between stationary fluid-filled structures in the abdomen (which have a long T2 relaxation time) and adjacent soft tissue (which has a much shorter T2 relaxation time). Static or slow moving fluids within the biliary tree and pancreatic duct appear of high signal intensity on MRCP, whilst surrounding tissue is of reduced signal intensity. (WallnerBK ,et al 1991). 1 Heavily T2-weighted images were originally achieved using a gradient-echo (GRE) balanced steady-state free precession technique. A fast spin-echo (FSE) pulse sequence with a long echo time (TE) was then introduced shortly after, with the advantages of a higher signal-to-noise ratio and contrast-to-noise ratio, and a lower sensitivity to motion and susceptibility artefacts.
    [Show full text]
  • Ography C Virtual Colonoscopy for Screening
    466 Gut 2004;53:466 Gut: first published as on 11 February 2004. Downloaded from Please visit the Gut website (www.gutjnl.com) for links possible to generate three dimensional ultrasound cholangiograms. to these articles – many to full text. The authors prospectively evaluated the ability of this technique, compared with direct cholangiography (endoscopic retrograde cholangiopancreatography (ERCP)/percutaneous transhepatic cho- langiogram (PTC)) and MRCP, to detect and characterise biliary ....................................................................... obstruction in 40 patients. Experienced operators, who were blinded to the results of the other tests, evaluated images for Pseudo-pseudomembranous collagenous technical adequacy, presence and level of obstruction, and c suspected cause of any stricture. Compared with two dimensional colitis ultrasound, three dimensional analysis improved the assessment of m Yuan S, Reyes V, Bronner MP. Pseudomembranous collagenous colitis. Am J biliary anatomy in seven of 40 patients. Three dimensional Surg Pathol 2003;27:1375–9. ultrasound however visualised the peripapillary region less well Microscopic colitis has been divided into three types (Warren BF, et (80%) than MRCP (95%) and direct cholangiography (100%) but al. Histopathology 2002;40:374–6), all characterised by watery was superior at demonstrating the gall bladder and biliary tree diarrhoea and minimal mucosal changes at colonoscopy, asso- proximal to a stricture. All techniques were highly sensitive for ciated with an increase in lamina propria lymphocytes and minimal detection of biliary obstruction (100%) and each diagnosed the crypt architectural distortion. Of the three types, lymphocytic colitis likely cause in 90–95% of cases. Three dimensional ultrasound also has an increase in intraepithelial lymphocytes, collagenous detected the correct level of obstruction in 92% of cases compared colitis has a subepithelial collagen band, and microscopic colitis not with 95% for MRCP and 90% for ERCP/PTC.
    [Show full text]
  • Diagnosis and Management of Primary Sclerosing Cholangitis
    AASLD PRACTICE GUIDELINES Diagnosis and Management of Primary Sclerosing Cholangitis Roger Chapman,1 Johan Fevery,2 Anthony Kalloo,3 David M. Nagorney,4 Kirsten Muri Boberg,5 Benjamin Shneider,6 and Gregory J. Gores7 Preamble classification used by the Grading of Recommendation This guideline has been approved by the American Asso- Assessment, Development, and Evaluation (GRADE) ciation for the Study of Liver Diseases and represents the workgroup with minor modifications (Table 1).3 The position of the Association. These recommendations pro- strength of recommendations in the GRADE system are vide a data-supported approach. They are based on the classified as strong (class 1) or weak (class 2). The quality following: (1) formal review and analysis of the recently- of evidence supporting strong or weak recommendations published world literature on the topic (Medline search); is designated by one of three levels: high (level A), mod- (2) American College of Physicians Manual for Assessing erate (level B), or low-quality (level C). Health Practices and Designing Practice Guidelines1; (3) guideline policies, including the AASLD Policy on the Definition and Diagnosis Development and Use of Practice Guidelines and the Definitions. Primary sclerosing cholangitis (PSC) is a American Gastroenterological Association Policy State- chronic, cholestatic liver disease characterized by inflam- ment on Guidelines2; and (4) the experience of the au- mation and fibrosis of both intrahepatic and extrahepatic thors in the specified topic. bile ducts,4 leading to the formation of multifocal bile Intended for use by physicians, these recommenda- duct strictures. PSC is likely an immune mediated, pro- tions suggest preferred approaches to the diagnostic, ther- gressive disorder that eventually develops into cirrhosis, apeutic and preventative aspects of care.
    [Show full text]